| Product Code: ETC9517164 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Neuropathic Pain Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Neuropathic Pain Market - Industry Life Cycle |
3.4 Suriname Neuropathic Pain Market - Porter's Five Forces |
3.5 Suriname Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Suriname Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Suriname Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Suriname Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Suriname Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Suriname Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Suriname Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuropathic pain in Suriname |
4.2.2 Growing awareness about neuropathic pain treatments and management |
4.2.3 Advancements in medical technology and treatments for neuropathic pain |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in Suriname |
4.3.2 High cost of neuropathic pain treatments |
4.3.3 Lack of trained healthcare professionals in the field of neuropathic pain management |
5 Suriname Neuropathic Pain Market Trends |
6 Suriname Neuropathic Pain Market, By Types |
6.1 Suriname Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Suriname Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Suriname Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Suriname Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Suriname Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Suriname Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Suriname Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Suriname Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Suriname Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Suriname Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Suriname Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Suriname Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Suriname Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Suriname Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Suriname Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Suriname Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Suriname Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Suriname Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Suriname Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Suriname Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Suriname Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Suriname Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Suriname Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Suriname Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Suriname Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Suriname Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Suriname Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Suriname Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Suriname Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Suriname Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Suriname Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Suriname Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Suriname Neuropathic Pain Market Export to Major Countries |
7.2 Suriname Neuropathic Pain Market Imports from Major Countries |
8 Suriname Neuropathic Pain Market Key Performance Indicators |
8.1 Patient satisfaction rates with neuropathic pain treatments |
8.2 Number of healthcare facilities offering specialized neuropathic pain care |
8.3 Percentage of healthcare professionals trained in neuropathic pain management |
9 Suriname Neuropathic Pain Market - Opportunity Assessment |
9.1 Suriname Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Suriname Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Suriname Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Suriname Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Suriname Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Suriname Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Suriname Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Suriname Neuropathic Pain Market - Competitive Landscape |
10.1 Suriname Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Suriname Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here